In contrast, the radiation detection firm Landauer (LDR) proved to be the biggest laggard in the first half of the year. However, a number of recent regulatory changes that address shortfalls in U.S. hospital radiation monitoring appear likely to provide the company with an opportunity to turn their stock performance around.
From Bill Frels (Trades, Portfolio)’ Small Cap Fund Second Quarter 2014 Commentary.
